← Companies|Lenz Ther
LE

Lenz Ther

LENZ·NASDAQDel Mar CAFounded 201340 employees
Small CapbiotechPublicOphthalmology
Platform: LNZ100 Presb
Market Cap
$0.3B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (LENZ)
Loading LENZ stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
SemarasimodLEN-8766Phase 1/22NanobodyEZH2CGRPantHCCSMA
ZoricilimabLEN-8346Phase 22Cell TherapySOS1CAR-T BCMAMCCIgAN
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2025-09-15
Zoricilimab EMA Filing
MCC
Past
2027-02-08
Semarasimod Ph2 Data
HCC
Ph2 Data
2028-05-10
Zoricilimab Ph2 Data
IgAN
Ph2 Data
2030-11-28
Semarasimod Ph2 Data
HCC
Ph2 Data
2031-04-17
Zoricilimab Ph2 Data
IgAN
Ph2 Data